Home/Filings/4/0000950170-25-033838
4//SEC Filing

Vargeese Chandra 4

Accession 0000950170-25-033838

CIK 0001631574other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:14 PM ET

Size

9.0 KB

Accession

0000950170-25-033838

Insider Transaction Report

Form 4
Period: 2025-03-04
Vargeese Chandra
See Remarks
Transactions
  • Exercise/Conversion

    Share Option (right to buy)

    2025-03-0475,3320 total
    Exercise: $2.48Exp: 2025-03-10Ordinary Shares (75,332 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-03-04$2.48/sh+91,754$227,550362,687 total
  • Exercise/Conversion

    Share Option (right to buy)

    2025-03-0416,4220 total
    Exercise: $2.48Exp: 2025-03-10Ordinary Shares (16,422 underlying)
Footnotes (1)
  • [F1]The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Documents

1 file

Issuer

Wave Life Sciences Ltd.

CIK 0001631574

Entity typeother

Related Parties

1
  • filerCIK 0001657675

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:14 PM ET
Size
9.0 KB